Antiviral Therapies Shown to Be Effective against Multiple Viruses

Team says research results show existing safe-in-human broad-spectrum antivirals could be used on other viral infections.

Selecta to Co-Develop Immunotherapy with Sanofi, Launches Collab with Genethon

Both partnerships to use Selecta's SVP platform, designed to produce immune tolerance by attenuating the overactive response to specific antigens

Scientists Use MIPs to Crystallize Proteins for Research and Screening

Studies show MIPs act as efficient nucleants for hard to crystallize molecules.

Fairjourney to Develop Cancer Antibodies with BioRap, Hadasit

Fairjourney Biologics is teaming up with BioRap Technologies and Hadasit Medical Research Services and Development to develop antibodies against the anticancer target heparanase.

BioAgilytix Acquires IPM Biotech

Deal aimed at strengthening buyer's capabilities in large molecule bioanalysis and expanding its global presence

AstraZeneca to Sell Moventig’s European Rights to ProStrakan

$70 million deal covers the E.U, as well as Iceland, Norway, Switzerland and Liechtenstein.

Janssen Licenses Amunix’ Half-Life Extension Technology

Amunix struck a worldwide research collaboration and licensing deal with Janssen Biotech. Amunix will combine its XTEN half-life extension technology with protein and/or peptide therapeutics selected by Janssen.

BARDA Contracts Tetraphase for Antibiotic Development with $11.5M Up Front

If subsequent option periods are all completed, total award value would reach $67 million.

€1.2M Dutch Credit Will Support Phase I/II Trial of to-BBB’s Brain...

Money is expected to cover 35% of costs to develop 2B3-101 as a treatment for patients whose cancer has metastasized to the brain.

Llama Antibodies Used to Detect Botulinum Neurotoxins in Liquids

Scientists at the Southwest Foundation for Biomedical Research (SFBR) published their research in the journal PLoS ONE.

Recently Featured

Stay Connected

Scroll Up